Research Article
Effectiveness and Safety of Low Dose of Tenofovir Disoproxil Fumarate in Malagasy Patients with Chronic Hepatitis B
Table 3
Virological and biochemical response after low dose of TDF in naïve and experienced patients.
| | Variables | NA-naïve () | NA-experienced, viraemic () | NA-experienced, nonviraemic () |
| | 3 months | | | | | CVR, (%) | 11 (73.3) | 15 (75) | 10 (100) | | ALT normalization, (%) | 11 (73.3) | 12 (60) | 6 (60) | | 6 months | | | | | CVR, (%) | 12 (80) | 19 (95) | 10 (100) | | ALT normalization, (%) | 12 (80) | 17 (85) | 10 (100) | | 12 months | | | | | CVR, (%) | 14 (93.3) | 19 (95) | 10 (100) | | ALT normalization, (%) | 15 (100) | 20 (100) | 10 (100) |
|
|
CVR: complete virological response; ALT: alanine aminotransferase; NA: nucleos(t)ide analog.
|
